MannKind Corp. (Nasdaq: MNKD) $6.54. MannKind moving higher for the ninth-straight session following quarterly results issued on May 7th. One positive blog post might be aiding the move today, though a technical jump above the $5.50 price level might also be in play. At the end of April, shares held short were 45.72 million, or just over 30 percent of float.
Cleantech Solutions International, Inc. (Nasdaq: CLNT) $9.62. Cleantech popping over 150 percent to the new level as it announced becoming a certified supplier of components to China Petroleum and Chemical Corporation (NYSE: SNP) and China National Petroleum Corporation (CNPC).
Bristol-Myers Squibb Co. (NYSE: BMY) $47.48. Bristol-Myers Squibb up as Citi upgraded its rating from Neutral to Buy today.
Toll Brothers Inc. (NYSE: TOL) $39.25. Toll Bros. rising following strong Q2 results showing a beat on the top and bottom lines. Rackspace Hosting, Inc. (NYSE: RAX) $37.60. Rackspace was mostly in positive territory today, but did see a little move lower at the open and during Wednesday afternoon. On Tuesday, Amazon.com announced that its Amazon Web Services (AWS) GovCloud (U.S.) and all U.S. AWS Regions have received an Agency Authority to Operate (ATO) from the U.S. Department of Health and Human Services (HHS) under the Federal Risk and Authorization Management Program (FedRAMP) requirements at the Moderate impact level.
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) $4.405. Rigel lower along with broader market pressure as it announced the clinical advancement of three programs in development. For more color on the news, click here.
Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC) $2.91. Cyclacel closed a 6.83 million common stock offering, which priced at $3 per share. Underwriters exercised a 166,6667 overallotment.